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Abstract
Nasal carriage of Staphylococcus aureus contributes to an increased risk of developing an infection with the same bacterial strain. Genetic
regulatory elements and toxin-expressing genes are virulence factors associated with the pathogenic potential of S. aureus. We under-
took an extensive molecular characterization of methicillin-susceptible S. aureus (MSSA) carried by children. MSSA were recovered from
the nostrils of children. The presence of Panton-Valentine leukocidin (PVL), exfoliatins A and B (exfoA and exfoB), and the toxic-shock
staphylococcal toxin (TSST-1) and agr group typing were determined by quantitative PCR. A multiple-locus variable-number of tandem
repeat analysis (MLVA) assay was also performed for genotyping. Five hundred and seventy-two strains of MSSA were analysed. Overall,
30% were positive for toxin-expressing genes: 29% contained one toxin and 1.6% two toxins. The most commonly detected toxin gene
was tst, which was present in 145 (25%) strains. The TSST-1 gene was signiﬁcantly associated with the agr group 3 (OR 56.8, 95%
CI 32.0–100.8). MLVA analysis revealed a large diversity of genetic content and no clonal relationship was demonstrated among the
analysed MSSA strains. Multilocus sequence typing conﬁrmed this observation of diversity and identiﬁed ST45 as a frequent colonizer.
This broad diversity in MSSA carriage strains suggests a limited selection pressure in our geographical area.
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Introduction
Staphylococcus aureus is a major pathogen responsible for
both nosocomial and community-acquired infections. Three
basic clinical syndromes are reported with this bacterium: (i)
superﬁcial lesions, such as wound infections and skin
abscesses; (ii) systemic and deep-seated infections, such as
bacteraemia, endocarditis, pneumonia and osteomyelitis; and
(iii) toxaemic syndromes, such as staphylococcal scarlet
fever, toxic shock syndrome (TSS), staphylococcal scalded-
skin syndrome (SSSS), and staphylococcal food poisoning.
Most S. aureus infections occur in individuals who are already
colonized; accordingly, carriage has long been known to be
one of the most strongly associated risk factors for develop-
ing subsequent infections, including bacteraemia [1,2]. A
causal relationship between carriage and infection is further
supported by the fact that the nasal carriage strain and the
infecting strain very often possess similar genotypes. The
prevalence of colonization in the paediatric population is in
the range 18% to 52% [3]; younger children are signiﬁcantly
more often colonized than adolescents, and males more so
than females. The ecological niche of S. aureus is mainly the
anterior nares, although the skin, perineum and pharynx can
also harbour the organism [4].
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The expression of some S. aureus genes has been associ-
ated with deﬁned diseases or syndromes. For example, the
toxaemic syndromes are associated with the expression of
genes encoding for speciﬁc exotoxins such as toxic-shock
syndrome staphylococcal toxin (TSST-1) or exfoliatins, or
for staphylococcal enterotoxins. Other genetic determinants
of virulence coordinate the kinetics of the infection, such as
the global accessory gene regulator agr [5], as recently
reviewed [6]. agr comprises a regulatory element that con-
trols the temporal expression of most virulence factors of
S. aureus by simultaneously down-regulating surface proteins
and up-regulating proteases when reaching the stationary
phase. Strains can be further divided into four groups based
on the sequence of this global regulator. Although this can
be useful for typing purposes [7], these differences also
explain bacterial interference, as observed when two strains
from different agr types compete for the same niche [8]. In
addition, associations were revealed between agr-III and agr-
IV groups with TSS and SSSS syndromes, respectively [9,10].
A possible association between agr group and the acquisition
of lowered susceptibility to glycopeptides was also recently
suggested [11].
The prevalence of S. aureus nasal colonization has been
studied across age categories and is highest in infants and
young children, followed by a constant decline with age [12].
In the paediatric population, prevalence has been docu-
mented in speciﬁc countries but, to date, no systematic
description of the molecular epidemiology has ever been
performed on carriage isolates. In the present study, we per-
formed extensive molecular characterization of MSSA car-
riage isolates, beneﬁting from a prospective multicentre
Swiss study in children [13]. The analysis revealed an unsus-
pected genome-content diversity among the S. aureus strains
not only across eight participating Swiss children’s hospitals,
but also within each studied centre.
Materials and Methods
Participants
Methodological details of this multicentre, cross-sectional
study of children admitted to large Swiss teaching hospitals
during a 1-month surveillance period (16 March 2006 to 15
April 2006) have been published elsewhere [14]. Brieﬂy, the
study took place in eight children’s hospitals distributed
throughout Switzerland, in Geneva, Lausanne, Bern, Basel,
Zu¨rich, Luzern, Aarau and St-Gallen. The ﬁrst ﬁve institu-
tions comprise all the tertiary university hospitals in Switzer-
land. Children 4 weeks of age or older admitted for inpatient
care were eligible for enrolment. Exclusion criteria included
in-house transfers of patients and newborns admitted to
neonatal care directly after birth. After informed consent
had been obtained from parents or guardians, a nasal swab
from both nostrils was collected for culture of S. aureus
within 48 h of admission, and comprehensive patient charac-
teristics were entered into a standardized questionnaire.
Laboratory methods
One cotton swab per patient was used for both nostrils,
placed in transport medium M40 Transystem (Copan,
Brescia, Italy) and sent to the central bacteriological labora-
tory in Basel by overnight mail daily, except at weekends.
For culture of S. aureus, a chromogenic medium (MRSA ID
agar; bioMe´rieux, Marcy l‘Etoile, France) and a selective
enrichment broth (brain heart infusion broth with 6% NaCl;
Biomedics, Madrid, Spain) were inoculated. Oxacillin resis-
tance was tested by the use of a cefoxitin disk, according to
the guidelines of Clinical and Laboratory Standards Institute
(CLSA, formerly NCCLS) and as described previously [14].
After incubation overnight, the broth was subcultured on to
another chromogenic agar for S. aureus (Chromagar Staph.
aureus; Hy Laboratories, Rehovot, Israel). Identiﬁcation of
S. aureus was based on various traits such as typical growth
on a chromogenic medium and detection of clumping factor,
protein A, and capsular antigens (PASTOREX STAPH-
PLUS; Bio-Rad, Marnes-la-Coquette, France). Isolates were
then shipped to the Clinical Microbiology Laboratory of Gen-
eva using a dedicated transport system, cultured on sheep
blood agar and speciation was conﬁrmed by PCR determina-
tion of the femA gene of S. aureus [15].
DNA extraction
Isolates were stored at )80C in skim milk, directly from
fresh plate cultures. Before experiments, isolates were
thawed, plated on LB agar and assessed for purity. Genomic
DNA was extracted from one colony suspended in 200 lL
Tris-EDTA buffer (10 mM Tris, 1 mM EDTA) in the pres-
ence of 100 mg of glass beads, as previously described [16].
Genotyping
Toxinotyping for the presence of Panton-Valentine leukocidin
(PVL), exfoliatins A and B (exfoA and exfoB) and TSST-1 was
performed by quantitative (q)PCR as previously described
[17]. agr group typing was performed by a multiplex qPCR
assay [7]. Genotyping, using a high-throughput multiple-locus
variable-number of tandem repeat analysis (MLVA) assay,
which consisted of a multiplex PCR with 10 primer pairs,
was performed as previously reported [16,18]. In addition, a
commercial repPCR assay [19] (DiversiLab; bioMe´rieux) was
performed on the same strains, and multilocus sequence typ-
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ing (MLST) according to the methods described by Enright
et al. [20] on a representative panel of isolates.
Results
Study population
In total, 1736 children were eligible during this 1-month study
period, representing 1762 hospitalizations. Of these, 356
patients (20.2%) were not included because of parental refusal
(n = 88), > 48 h having elapsed subsquent to admission
(n = 72) and various other reasons (n = 196), such as a short
hospital stay with discharge before enrolment, language
barriers, or the absence of parents. Finally, nasal swabs were
available from 1363 hospitalizations in 1350 patients. Overall,
572 (42%) strains of MSSA and one strain of MRSA were iso-
lated from 562 swabs. The fact that we considered 572 strains
and not 562 as previously described [14] is explained by the
better sensitivity of our genotyping analyses, allowing us to
distinguish strains that were apparently similar and belonging
to the same colony but that differed according to their MLVA
proﬁle, toxin content or agr group. The prevalence of nasal
colonization with S. aureus was in the range 36% to 50%
among the study sites (Table 1). Of 13 patients hospitalized
twice, only four (31%) were carrying S. aureus at both investi-
gation points. Ninety positive swabs (16%) were from children
< 1 year old, 200 (36%) from children aged 1–6 years old, and
272 (48%) from children ‡7 years or more. Carriage occurred
in 290 females (52%) and 272 males.
Three hundred forty-one children (61%) were of Swiss
origin, 132 (24%) originated in Western Europe (Germany,
England, France, Italy, Spain, Portugal, Belgium), 41 (8.4%)
came from Eastern Europe (Kosovo, Turkey, Romania,
Greece, Macedonia), 41 (7.3%) from other continents; and
one (0.2%) had missing data.
Classiﬁcation of agr groups
From 572 strains of S. aureus, 256 (45%) displayed agr I, 89
(16%) displayed agr II, 156 (27%) displayed agr III, 66 (12%)
displayed agr IV type, and ﬁve (0.9%) remained unclassiﬁed.
The different agr groups were distributed very similarly
across the eight study centres (Fig. 1). However, in most
centres, agr groups I and III were more frequently recovered
and accounted for 66–79% of all strains (Table 1).
Distribution of toxin genes
A total of 172 strains (30%) of S. aureus were positive for
toxin-expressing genes. Twenty-nine percent contained one
toxin and 1.6% two toxins. The TSST-1 gene was the most
common, present in 145 (25%) strains. Exfoliatins A, B, and
PVL genes were less common, being recovered in 22 (3.8%),
seven (1.2%) and nine (1.6%) strains, respectively.
Correlation between agr groups, toxin contents and demo-
graphic variables
We then attempted to correlate agr groups and toxin con-
tents with the variables: hospital location; patient gender,
age, and country of origin; previous antibiotic use during
‡7 days, recent hospital stay or hospitalization of a house-
hold member within the last 3 months. None of these vari-
ables could be linked to a particular agr group. However, a
strong association was detected between the presence of the
TSST-1 gene and agr group 3 (OR 56.8; 95% CI 32.0–100.8).
TABLE 1. Strain classiﬁcation depending on agr group, toxin
content and study site
agr
Toxin
content GE VD BE ZH AR LU SG BS
Swabs 81 81 55 74 47 72 75 87
% MSSA 40.5 40.7 35.9 37.2 42.0 48.0 50.0 43.5
agr 1 TSST), PVL) 23 28 30 24 24 32 30 44
TSST+, PVL) 4 3 2 4 1 2 1 3
TSST), PVL+ 0 0 0 0 0 0 0 1
agr 2 TSST), PVL) 11 15 10 13 5 9 7 9
TSST+, PVL) 2 0 0 1 0 0 1 0
TSST), PVL+ 0 1 0 1 0 0 0 0
TSST), ExfoA+ 1 3 0 0 0 0 0 0
agr 3 TSST), PVL) 9 4 0 3 3 6 6 4
TSST+, PVL) 20 21 10 18 4 17 15 12
TSST), PVL+ 0 1 1 0 0 0 0 1
TSST+, PVL+ 0 0 0 0 0 0 0 0
TSST), ExfoA+ 0 0 0 0 0 0 1 0
agr 4 TSST), PVL) 7 2 2 7 8 5 7 8
TSST+, PVL) 0 0 0 0 1 0 0 0
TSST), PVL+ 0 1 0 0 0 0 0 1
ExfoA+ 1 0 0 1 0 1 4 2
ExfoA+, PVL+ 0 0 0 0 0 0 1 0
ExfoA+, ExfoB+ 1 1 0 2 0 0 2 1
agr ND TSST), PVL) 1 1 0 0 0 0 0 1
TSST+, PVL) 1 0 0 0 1 0 0 0
GE, Geneva; VD, Lausanne; BE, Bern; BL, Basel; ZH, Zu¨rich; LU, Luzern; AA,
Aarau; SG, St-Gallen.
BS = 87
AA = 47
53%
ZH = 74
38%
55%20%
15% 28%
VD = 81
39%32%
SG = 75
41%
29%
GE = 81
33%
agr 1
47%32%58%
20%
37% agr 2agr 3
agr 4
LU = 72
BE = 55
agr ND
FIG. 1. agr repartition in study sites.
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The TSST-1 gene was present in only 8% of agr I group, 4%
of agr II, 1.5% of agr IV, but 76% of agr III group (Table 2).
Interestingly, analysis suggested that agr 1 was frequently
associated with the absence of TSST-1 (237 of 512 strains).
No further signiﬁcant association was demonstrated
between any of the other three toxins (PVL, exfoA and
exfoB) and the different agr groups.
Genotyping analysis
We performed a genotyping analysis to assess whether com-
mon clones were circulating in Switzerland. To allow for large
numbers, we decided to concentrate our MLVA analysis on
agr 3/TSST-1 positive strains recovered in all study sites. A
RepPCR tree yielded to two major clusters of similar size. A
homogeneous cluster composed of isolates showing sequence
TABLE 2. Toxin expressing gene in
the agr groups
agr PVL+ PVL) TSST) 1+ TSST) 1) ExfoA+ ExfoA) ExfoB+ ExfoB)
1 (n = 256) 1 255 20 236 0 256 0 256
2 (n = 89) 2 87 4 85 4 85 0 89
3 (n = 156) 3 153 118* 38 1 155 0 156
4 (n = 66) 3 63 1 65 17 49 7 59
*agr 3/TSST-1 positive: signiﬁcant association (OR 56.8, 95% CI 32.0–100.8).
(a)
(b)
FIG. 2. Genotyping of tst positive isolates
identiﬁed in Geneva. Clustering trees
obtained using a commercially available
repPCR assay DiversiLab (bioMe´rieux) (a)
or with a multiple-locus variable-number
of tandem repeat analysis (MLVA) assay
(b). Sequence type of representative iso-
lates are indicated to the right of each
panel. Black rectangles indicate the posi-
tion of the main cluster of isolates com-
posed of ST45 strains. MLST, multilocus
sequence typing.
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type 45 (ST45) on the one hand, and a very heterogeneous
cluster composed of strains appearing highly related on the
other. Additionally, two isolates appeared to be totally unre-
lated to any other strain (Fig. 2a). MLST analysis conﬁrmed
that the main cluster was composed of clonal isolates with
sequence type 45. The other cluster contained numerous dif-
ferent sequence types (Fig. 2a). Fig. 2b shows the tree
obtained by a MLVA assay that allows various genetic back-
grounds among the isolates to be distinguished. Only two
pairs of isolates appeared genetically-related (GE176, 59 and
166, 93A) but the tree structure revealed an overall striking
diversity of genetic content, with approximately 15 different
combinations of repeated regions in this collection of strains
and a large cluster composed of isolates identiﬁed as ST45 by
MLST. The presence of the tst gene does not appear to be
associated with any speciﬁc genetic background but rather to
be dispersed across different unrelated strains.
Discussion
We analysed strains collected from 1350 children hospital-
ized in eight Swiss paediatric hospitals during a 1-month sur-
veillance period. Overall, we identiﬁed 572 strains of
S. aureus from 562 children, corresponding to an overall
prevalence of 42%. Among the eight centres, carriage
prevalence was in the range 36% to 50%, in the Bern and
St-Gallen areas, respectively. This prevalence appears similar
to that reported in other studies [21,22] but slightly higher
than that observed in 2003 by Shopsin and Kreiswirth [23]
who reported a 35% MSSA carriage in healthy children visit-
ing a clinic. Only one child in our investigation was colonized
with MRSA, and this parallels other studies that have shown
that, despite an increase in MRSA prevalence in the hospital
settings, MRSA carriage remains stable and low in children in
the community [23,24], regardless of whether in the healthy
population or in patients requiring hospitalization [25]. Over-
all, age, sex, use of antibiotics for ‡7 days and recent hospi-
talization of a household member were not found to be
independent risk factors for TSST-1 positive S. aureus car-
riage or for a speciﬁc agr- group in our studied population.
However, premature babies, and patients with acquired or
congenital immunodeﬁciencies, with HIV, with intravascular
devices, and those undergoing surgery are at increased risk
of developing staphylococcal infections [26]. Efﬁcient elimina-
tion of nasal colonization of strains carrying a speciﬁc genetic
background could theoretically reduce the infection rates in
speciﬁc populations identiﬁed as high risk groups [27,28].
Recently, Melles et al. [21] compared the strains recovered
from HIV patients (who are prone to develop S. aureus infec-
tions with persistent carriage) with those recovered from
healthy subjects and found them to be ‘strongly overlapping’
in genetic content assessed by the ampliﬁed fragment length
polymorphism assay.
The accessory gene regulator (agr) is a crucial component
of S. aureus involved in the temporal expression of numerous
bacterial virulence factors. In our population, agr type I was
the most abundant allele in seven of the eight geographical
areas studied. Geneva was the only region with a majority of
strains harbouring a type III agr allele. In the present study,
the distribution of agr type was similar to that observed else-
where [31], although no evidence of a massively predominant
allele was found. Overall, our strain population contained 30%
of isolates harbouring at least one potent toxin (e.g. exfoA or
exfoB, TSST-1 or PVL). Most of the isolates with either of the
two exfoliatin toxins belong to agr II and IV groups, which is
consistent with the study of Jarraud et al. [30]. The TSST gene
was predominantly found in strains harbouring agr-III, which
also conﬁrms a previous observation [10,29]. Our group
recently published the epidemiological features of community-
acquired MRSA in Geneva. In that study, we showed that 60%
of community-associated strains harboured at least one toxin
gene [17], which is twice the prevalence of strains found posi-
tive for similar toxins in this MSSA population. PVL was found
in 1.6% of this MSSA cohort, which is a number signiﬁcantly
lower than that reported by others in infecting MSSA strains
in southern European countries but strictly identical to the
prevalence found in bacteraemia isolates in other European
countries [32].
A broad genetic diversity was observed in this collection
of S. aureus strains, and no clonal groups were observed in
any of the centres. This suggests that the environmental
selection pressure (e.g. of antimicrobial usage, country of ori-
gin, etc.) acting on S. aureus is very low in this population. A
recent review suggested that colonizing and infecting strains
share some common evolutionary features [33] partly
related to environmental and host factors. The combination
host-strain appears determinant in the co-evolution to either
long-term asymptomatic carriage or to the development of
staphylococcal infection [33].
Rapid genotyping using MLVA has been shown previously
to provide at least similar discriminatory power to PFGE
[16] and to allow further subdivision of groups of isolates
that appear clonal when other genotyping methods such as
MLST [17] or PFGE [16] are used. On our collection of
strains harbouring the tst gene, MLVA was more discrimina-
tive than repPCR or MLST. MLST and repPCR identiﬁed a
major cluster of ST45 isolates and numerous individual
isolates of various phylogenetic origins. The MLVA assay
shows the striking diversity of genetic backgrounds in our
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population, even among ST45 isolates. This observation is in
accordance with a previous report on MRSA showing that
ST45 encompasses a rather broad spectrum of strains with
different genetic features and staphylococcal cassette chro-
mosome mec (SCCmec) elements [34]. The properties of
such typing strategies were previously reported by Tenover
et al. [19] who showed that DiversiLab was signiﬁcantly less
discriminative than PFGE. A previous report on MSSA from
German carriers showed that the tst gene was mainly har-
boured by strains from the CC30 group [35], a ﬁnding that
differs from the paediatric carriage as observed in our geo-
graphical area. This was conﬁrmed by the absence of clusters
containing strains harbouring similar agr type or toxin con-
tent. This observation is strikingly different from a similar
analysis performed on MRSA populations, which suggested
that a limited number of genetic contents only are able to
receive a SCCmec element [17]. Surprisingly, this extreme
diversity of genetic backgrounds has also been observed very
recently in children colonized by methicillin susceptible
Staphylococcus epidermidis [36]. This suggests that the restric-
tion observed in MRSA is rather a result of antibiotic pres-
sure than to the genetic background.
Our analysis has some limitations. The cross-sectional
design only measures carriage prevalence and no serial cul-
tures were achieved. The children enrolled in the study had
been admitted to hospital and are therefore not necessarily
representative of the whole children’s population in the
country. Despite the fact that the present study was
designed to determine the carriage rates of MSSA and
MRSA, most clinical and epidemiological items in the ques-
tionnaire were based on the literature regarding MRSA.
Our observations suggest that the environmental selection
pressure on S. aureus is likely to be moderate in this popula-
tion. Further work would allow us to discover whether
infectious strains share the same genotypic characteristics as
colonizing strains, within the same patient population.
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